PFIZER INC Depreciation & Amortization 2007-2026 | PFE
Beta
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is PFIZER INC's current depreciation & amortization?
PFIZER INC (PFE) annual depreciation & amortization for 2025 was $6.59B, a 6.00% decline from 2024. PFIZER INC depreciation & amortization for the quarter ending March 29, 2026 was $1.61B.
What was PFIZER INC's depreciation & amortization in 2024?
PFIZER INC annual depreciation & amortization for 2024 was $7.01B, a 11.49% increase from 2023.
What was PFIZER INC's depreciation & amortization in 2023?
PFIZER INC annual depreciation & amortization for 2023 was $6.29B, a 24.21% increase from 2022.
What is PFIZER INC's 5-year depreciation & amortization CAGR?
PFIZER INC depreciation & amortization grew at a compound annual growth rate (CAGR) of 7.09% from FY2020 to FY2025, going from $4.68B to $6.59B over 5 years.
Depreciation & Amortization History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+7.1%
FY2020
$4.68B
→
FY2025
$6.59B
07080910111213141516171819202122232425
5 years selected
Depreciation & Amortization History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $6.59B | -6.0% | 10-K |
| FY2024 | $7.01B | +11.5% | 10-K |
| FY2023 | $6.29B | +24.2% | 10-K |
| FY2022 | $5.06B | -2.4% | 10-K |
| FY2021 | $5.19B | +10.9% | 10-K |
| FY2020 | $4.68B | -18.7% | 10-K |
| FY2019 | $5.75B | -9.9% | 10-K |
| FY2018 | $6.38B | +1.8% | 10-K |
| FY2017 | $6.27B | +8.9% | 10-K |
| FY2016 | $5.76B | +11.6% | 10-K |
| FY2015 | $5.16B | -6.9% | 10-K |
| FY2014 | $5.54B | -12.2% | 10-K |
| FY2013 | $6.31B | -14.7% | 10-K |
| FY2012 | $7.39B | -15.0% | 10-K |
| FY2011 | $8.70B | +3.6% | 10-K |
| FY2010 | $8.40B | +76.6% | 10-K |
| FY2009 | $4.76B | -6.5% | 10-K |
| FY2008 | $5.09B | -2.1% | 10-K |
| FY2007 | $5.20B | - | 10-K |
Company: PFIZER INCTicker: PFESector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →